SiTime (SITM) Set to Join S&P MidCap 400; Emergent BioSolutions (EBS) to Join S&P SmallCap 600

November 23, 2021 9:06 AM EST

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

SiTime Corp. (NASD: SITM) will replace Emergent BioSolutions Inc. (NYSE: EBS) in the S&P MidCap 400, and Emergent BioSolutions will replace Domtar Corp. (NYSE: UFS) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, November 30. Paper Excellence B.V. is acquiring Domtar in a deal expected to be completed soon pending final conditions. Emergent BioSolutions is more representative of the small-cap market space.

Following is a summary of the changes that will take place prior to the open of trading on the effective date:

Effective Date

Index Name

Action

Company Name

Ticker

GICS Sector

Nov 30, 2021

S&P MidCap 400

Addition

SiTime

SITM

Information Technology

S&P MidCap 400

Deletion

Emergent BioSolutions

EBS

Health Care

S&P SmallCap 600

Addition

Emergent BioSolutions

EBS

Health Care

S&P SmallCap 600

Deletion

Domtar

UFS

Materials

For more information about S&P Dow Jones Indices, please visit www.spdji.com



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News, Index Changes

Related Entities

Standard & Poor's